Covert treatment in psychiatry: Do no harm, true, but also dare to care

Mens Sana Monographs

Volumn 6, Issue 1, 2008, Pages 81-109

  Singh, Ajai ^a  

^a NONE   (India)

Author keywords

Advance directive; Autonomy; Benefi cence; Covert treatment; Dare to care; Do no harm; Health care proxy; Insight unconscious; Maladeintent; Non malfeasance; Noncompliance; Relapse prevention; Secrecy; Surreptitious prescribing; Unhealthy staff practices

Indexed keywords

EID: 44349118060     PISSN: 09731229     EISSN: 19984014     Source Type: Journal    
DOI: 10.4103/0973-1229.40566     Document Type: Article

References (42)

1. Ahern L., Van Tosh L., (2005), The irreversible damage caused by surreptitious prescribing, Psychiatric Services, 56, p383.
2. Appelbaum P.S., (2004), Law & Psychiatry: Psychiatric Advance Directives and the Treatment of Committed Patients, Psychiatr Serv, 55(7), p751-763.
3. Chua S., Choy K., Wong J., (2001), Concealment of medication in patients' food, The Lancet, 357, p1369.
4. Clarke M., Whitty P., Browne S., McTigue O., Kamali M., Gervin M., Kinsella A., Waddington J.L., Larkin C., O'Callaghan E., (2006), Untreated illness and outcome of psychosis, Br. J. Psychiatry, 189(3), p235-240.
5. College The, (2004), College Statement on Covert Administration of Medicines, Psychiatric Bulletin, 28, p385-386.
6. Cormac I., Tihanyi P., (2006), Meeting the mental and physical healthcare needs of carers, Advances in Psychiatric Treatment, 12, p162-172.
7. Cuijpers P., (1999), The effects of family interventions on relatives' burden: a meta-analysis, Journal of Mental Health, 8, p275-285.
8. Department Of Health And Welsh Office, (1999), Code of Practice, Mental Health Act 1983. London: HMSO.
9. Foti M.E., Bartels S.J., Merriman M.P., Fletcher K.E., Van Citters A.D., (2005), Medical Advance Care Planning for Persons With Serious Mental Illness, Psychiatr Serv, 56(5), p576-584.
10. Gallagher E.M., (1998), Advance directives for psychiatric care: a theoretical and practical overview for legal professionals, Psychol Public Policy Law, 4(3), p746-787.
11. Geller J.L., (2000), The use of advance directives by persons with serious mental illness for psychiatric treatment, Psychiatr Q, 71(1), p1-13.
12. Griffith D., Bell A., (1996), Commentary: treatment was not unethical, British Medical Journal, 313, p1250, 1996.
13. Kellet J. M., (1996), An Ethical Dilemma: A nurse is suspended, British Medical Journal, 313, p1249-1250.helle Kelly, Sandra Dunbar, John E Gray, Richard L O'Reilly
14. Kelly M., Dunbar S., Gray J.E., O'Reilly R.L., (2002), Treatment delays for involuntary psychiatric patients associated with reviews of treatment capacity, Canadian Journal of Psychiatry, 47, p181-185.
15. Levin A., (2005), Covert Drug Administration: 'Win Battle, But Lose War', Psychiatric News, 40(10), p10.
16. Loebel A.D., Lieberman J.A., Alvir J.M., Mayerhoff D.I., Geisler S.H., Szymanski S.R., (1992), Duration of psychosis and outcome in first-episode schizophrenia, American Journal of Psychiatry, 149, p1183-1188.
17. Norman R., Malla A., (2001), Duration of untreated psychosis: a critical examination of the concept and its importance, Psychological Medicine, 31, p381-400.
18. O'Connell M.J., Stein C.H., (2005), Psychiatric advance directives: perspectives of community stakeholders, Adm Policy Ment Health, 32(3), p241-265.
19. Øyvind K., Knut E., (2005), Concealment of drugs in food and beverages in nursing homes: cross sectional study, BMJ, 330, p20.
20. Papageorgiou A., King M., Janmohamed A., Davidson O., Dawson J., (2002), Advance directives for patients compulsorily admitted to hospital with serious mental illness: Randomised controlled trial, Br J Psychiatry, 181(6), p513-519.
21. Part IVC (Medical and dental treatment) Mental Health Ordinance, (2007), Chap 136. Earlier available at: http://www.justice.gov.hk/blis.nsf/ (Accessed March 14, 2001). Now available as 'Consent to Medical and Dental Treatment' at: http://www.adultguardianship.org.hk/leaflet/L12E.pdf (Accessed 26 Dec 2007).
22. Perkins D.O., Gu H., Boteva K., Lieberman J.A., (2005), Relationship Between Duration of Untreated Psychosis and Outcome in First-Episode Schizophrenia: A Critical Review and Meta-Analysis, Am J Psychiatry, 162, p1785-1804.
23. Perlick D.A., Rosenheck R.A., Clarkin J.F., Maciejewski P.K., Sirey J., Struening E., Link B.G., (2004), Impact of Family Burden and affective Response on Clinical Outcome Among Patients With Bipolar Disorder, Psychiatr Serv, 55, p1029-1035.
24. Pilling S., Bebbington P., Kuipers E., Garety P., Geddes J. orbach G., Morgan C., (2002), Psychological treatments in schizophrenia: I. Meta-analysis of family intervention and cognitive behaviour therapy, Psychological Medicine, 32, p763-782.
25. Raymark P.H., Balzer W.K., Doherty M.E., Warren K., Meeske J., Tape T.G., Wigton R.S., (1995), Advance directives: a policy-capturing approach, Med Decis Making, 15(3), p217-226.
26. Sellwood W., Tarrier N., Quinn J., Barrowclough C., (2003), The family and compliance in schizophrenia: the influence of clinical variables, relatives' knowledge and expressed emotion, Psychological Medicine, 33, p91-96.
27. Singh A., Singh S., (2006), To cure sometimes, to comfort always, to hurt the least, to harm never [Editorial]. In: What Medicine Means To Me. (A.R. Singh and S.A. Singh Eds.), MSM, 4(1), p8-9.
28. Singh A.R., (2007a), The task before psychiatry today, Indian J Psychiatry, 49, p60-65.
29. Singh S.P., (2007b), Outcome measures in early psychosis: Relevance of duration of untreated psychosis, Br. J. Psychiatry, 191:50, s58-s63.
30. Srebnik D., Appelbaum P.S., Russo J., (2004), Assessing competence to complete psychiatric advance directives with the competence assessment tool for psychiatric advance directives, Compr Psychiatry, 45(4), p239-245.
31. Srebnik D.S., Russo J., Sage J., Peto T., Zick E., (2003), Interest in Psychiatric Advance Directives Among High Users of Crisis Services and Hospitalization, Psychiatr Serv, 54(7), p981-986.
32. Srebnik D.S., Rutherford L.T., Peto T., Russo J., Zick E., Jaffe C., Holtzheimer P., (2005), The Content and Clinical Utility of Psychiatric Advance Directives, Psychiatr Serv, 56(5), p592-598.
33. Sykes J.B. (Ed), (1985), The Concise Oxford Dictionary of Current English, Seventh Edn. 1982, Reprinted 1985, p219 and 1075. Bombay: Ox Uni Press.
34. Swanson J., Swartz M., Ferron J., Elbogen E., Van Dorn R., (2006), Psychiatric advance directives among public mental health consumers in five u.s. Cities: prevalence, demand and correlates, J Am Acad Psychiatry Law, 34(1), p43-57.
35. Treloar A., Beats B., Philpot M., (2000), A pill in the sandwich: covert medication in food and drink, Journal of the Royal Society of Medicine, 93, p408-411.
36. Treloar A., Beck S., Paton C., (2001a), Administering medications to patients with dementia and other organic cognitive syndromes, Advances in Psychiatric Treatment, 7, p444-452.
37. Treloar A., Philpot M., Beats B., (2001b), Concealing medication in patients' food, Lancet, 357, p62-64.
38. Valmana A., Rutherford J., (1997), Letters. Suspension of nurse who gave drug on consultant's instructions. Over a third of psychiatrists had given a drug surreptitiously or lied about a drug, British Medical Journal, 314, p299-300.
39. Welsh S., Deahl M., (2002), Covert medication-ever ethically justifiable? Psychiatric Bulletin, 26, p123-126.
40. Whitty P., Devitt P., (2005), Surreptitious prescribing in psychiatric practice, Psychiatric Services, 56, p481-483.
41. Widdershoven G., Berghmans R., (2001), Advance directives in psychiatric care: a narrative approach, J. Med. Ethics, 27(2), p92-97.
42. Wong J.G.W.S., Poon Y., Hui E.C., (2005), "I can put the medicine in his soup, Doctor!" J Med Ethics, 31, p262-265.